{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,1,26]],"date-time":"2024-01-26T19:38:03Z","timestamp":1706297883335},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[1993,5,1]],"date-time":"1993-05-01T00:00:00Z","timestamp":736214400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[1993,5]]},"DOI":"10.1007\/bf01738474","type":"journal-article","created":{"date-parts":[[2005,6,13]],"date-time":"2005-06-13T10:27:46Z","timestamp":1118658466000},"page":"247-249","source":"Crossref","is-referenced-by-count":5,"title":["MCNU in the treatment of essential thrombocythemia \u2014 a pilot study"],"prefix":"10.1007","volume":"66","author":[{"given":"H.","family":"Murakami","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Tamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Sawamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BF01738474_CR1","doi-asserted-by":"crossref","first-page":"2440","DOI":"10.1002\/1097-0142(19861201)58:11<2440::AID-CNCR2820581115>3.0.CO;2-Y","volume":"58","author":"S Bellucci","year":"1986","unstructured":"Bellucci S, Janvier M, Tobelem G, Frandrin G, Charpak Y, Berger R, Boiron M (1986) Essential thrombocythemias. Cancer 58: 2440\u20132447","journal-title":"Cancer"},{"key":"BF01738474_CR2","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1182\/blood.V36.1.61.61","volume":"36","author":"TA Bensinger","year":"1970","unstructured":"Bensinger TA, Logue GL, Rundles RW (1970) Hemorrhagic thrombocythemia: control of postsplenectomy thrombocytosis with melphalan. Blood 36: 61\u201369","journal-title":"Blood"},{"key":"BF01738474_CR3","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/S0065-230X(08)60343-7","volume":"16","author":"SK Carter","year":"1972","unstructured":"Carter SK, Schabel FM jr, Broder LE, Johnston TP (1972) 1,3-Bis (2-chloroethyl)-1-nitrosourea (BCNU) and other nitrosoureas in cancer treatment: a review. Adv Cancer Res 16: 273\u2013332","journal-title":"Adv Cancer Res"},{"key":"BF01738474_CR4","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1182\/blood.V63.1.51.51","volume":"63","author":"DC Case","year":"1984","unstructured":"Case DC (1984) Therapy of essential thrombocythemia with thiotepa and chlorambucil. Blood 63: 51\u201354","journal-title":"Blood"},{"key":"BF01738474_CR5","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1111\/j.1600-0609.1990.tb00355.x","volume":"44","author":"J Kutti","year":"1990","unstructured":"Kutti J (1990) The management of thrombocytosis. Eur J Haematol 44: 81\u201388","journal-title":"Eur J Haematol"},{"key":"BF01738474_CR6","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1111\/j.1600-0609.1988.tb00212.x","volume":"41","author":"E Lofvenberg","year":"1988","unstructured":"Lofvenberg E, Wahlin A (1988) Management of polycythaemia vera, essential thrombocythaemia and myelofibrosis with hydroxyurea. Eur J Haematol 41: 375\u2013381","journal-title":"Eur J Haematol"},{"key":"BF01738474_CR7","first-page":"1518","volume":"10","author":"T Masaoka","year":"1983","unstructured":"Masaoka T, Kimura K, Miyazaki T (1983) Phase-II study with methyl-6-[[[(2-chloroethyl) nitrosoamino] carbonyl] amino]-6-deoxy-\u03b1-D-glucopyranoside (MCNU) in hematological malignancies. Jpn J Cancer Chemother 10: 1518\u20131523","journal-title":"Jpn J Cancer Chemother"},{"key":"BF01738474_CR8","first-page":"271","volume":"33","author":"T Masaoka","year":"1985","unstructured":"Masaoka T, Shibata H, Nagai K, Kanamaru A, Kitani T, Taniguchi N, Yonezawa T, Kawagoe H, Hirata M, Horiuchi A, Tsubaki K, Ohokubo H, Yasunaga K, Okamoto Y, Fujitake H, Sasada M, Nakamura T (1985) Clinical phase-II study of MCNU (ranimustine) in hematological malignant diseases. Chemotherapy 33: 271\u2013278","journal-title":"Chemotherapy"},{"key":"BF01738474_CR9","first-page":"1495","volume":"66","author":"S Murphy","year":"1982","unstructured":"Murphy S, Rosenthal DS, Weinfeld A, Briere J, Faguet GB, Knospe WH, Landaw SA, Laszlo J, Pisciotta AV, Tartaglia AP, Goldberg JD, Berk PD, Donovan PB, Wasserman LR (1982) Essential thrombocythemia: response during first year of therapy with melphalan and radioactive phosphorus: a Polycythemia Vera Study Group report. Cancer Treat Rep 66: 1495\u20131500","journal-title":"Cancer Treat Rep"},{"key":"BF01738474_CR10","first-page":"177","volume":"23","author":"S Murphy","year":"1986","unstructured":"Murphy S, Hand H, Rosenthal D, Laszlo J (1986) Essential thrombocythemia: an interim report from the polycythemia Vera Study Group. Semin Hematol 23: 177\u2013182","journal-title":"Semin Hematol"},{"key":"BF01738474_CR11","first-page":"380A","volume":"24","author":"L Panasci","year":"1976","unstructured":"Panasci L, Fox P, Woolley P, Schein PS (1976) Pharmacologic studies of nonmyelosuppressive nitrosourea antitumor agents. Clin Res 24: 380A","journal-title":"Clin Res"},{"key":"BF01738474_CR12","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1111\/j.1600-0609.1985.tb02270.x","volume":"35","author":"BE Pauw de","year":"1985","unstructured":"Pauw BE de, van Bergen ANL, Haanen C, Steenbergen J (1985) Intermittent melphalan in the treatment of essential thrombocytosis with haemorrhage or thrombosis. Scand J Haematol 35: 448\u2013450","journal-title":"Scand J Haematol"},{"key":"BF01738474_CR13","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1111\/j.1365-2141.1991.tb04408.x","volume":"78","author":"TC Pearson","year":"1991","unstructured":"Pearson TC (1991) Primary thrombocythemia: diagnosis and management. Br J Haematol 78: 145\u2013148","journal-title":"Br J Haematol"},{"key":"BF01738474_CR14","first-page":"69","volume":"10","author":"AI Schafer","year":"1991","unstructured":"Schafer AI (1991) Essential thrombocythemia. Prog Hemost Thromb 10: 69\u201396","journal-title":"Prog Hemost Thromb"},{"key":"BF01738474_CR15","first-page":"801","volume":"60","author":"PS Schein","year":"1976","unstructured":"Schein PS, Panasci L, Woolley P, Anderson T (1976) Pharmacology of chlorozotocin (NSC-178248), a new nitrosourea antitumor agent. Cancer Treat Rep 60: 801\u2013805","journal-title":"Cancer Treat Rep"},{"key":"BF01738474_CR16","first-page":"961","volume":"63","author":"S Sekido","year":"1979","unstructured":"Sekido S, Ninomiya K, Iwasaki M (1979) Biologic activity of MCNU: a new antitumor agent. Cancer Treat Rep 63: 961\u2013970","journal-title":"Cancer Treat Rep"},{"key":"BF01738474_CR17","first-page":"149","volume":"66","author":"F Shimizu","year":"1975","unstructured":"Shimizu F, Arakawa M (1975) Effect of 3-[(4-amino-2-methyl-5-pyrimidinyl) methyl]-1-(2-chloroethyl)-1-nitrosourea hydrochloride on lymphoid leukemia L-1210. Gan 66: 149\u2013154","journal-title":"Gan"},{"key":"BF01738474_CR18","first-page":"290","volume":"8","author":"T Takubo","year":"1981","unstructured":"Takubo T, Namiuchi S, Ueda T, Shibata H, Nakamura H, Masaoka T, Yoshitake J, Ishigami S (1981) Effect of 3-[(4-amino-2-methyl-5-pyrimidinyl)methyl]-1-(2-chloroethyl)-1-nitrosourea hydrochloride (ACNU) on chronic myelocytic leukemia. Jpn J Cancer Chemother 8: 290\u2013293","journal-title":"Jpn J Cancer Chemother"},{"key":"BF01738474_CR19","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S0305-7372(74)80015-0","volume":"1","author":"TH Wasserman","year":"1974","unstructured":"Wasserman TH (1974) Review of CCNU in clinical cancer therapy. Cancer Treat Rev 1: 131\u2013151","journal-title":"Cancer Treat Rev"},{"key":"BF01738474_CR20","first-page":"1332","volume":"19","author":"H Yoshikawa","year":"1978","unstructured":"Yoshikawa H (1978) AAAP therapy for relapse of acute leukemia. Jpn J Clin Hematol 19: 1332\u20131340","journal-title":"Jpn J Clin Hematol"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01738474.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF01738474\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01738474","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,26]],"date-time":"2024-01-26T18:50:33Z","timestamp":1706295033000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF01738474"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1993,5]]},"references-count":20,"journal-issue":{"issue":"5","published-print":{"date-parts":[[1993,5]]}},"alternative-id":["BF01738474"],"URL":"https:\/\/doi.org\/10.1007\/bf01738474","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"value":"0939-5555","type":"print"},{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[1993,5]]}}}